OS Therapies Inc
BiotechnologyCancer Immunotherapy
Grasonville, MD
About
Ostherapies is a clinical-stage biotechnology company focused on developing immunotherapies that activate the patient's immune system to fight HER2-expressing cancers. The firm's primary objective is to advance its lead therapy through clinical trials, initially targeting osteosarcoma, a cancer that has not seen new treatments in over three decades.
Company Values
The company is pioneering a new treatment for osteosarcoma, addressing a critical unmet need that has persisted for more than 30 years, while also targeting other aggressive solid tumors.